For Most Patients, Only Spontaneous MI Is Relevant
6 min.
Novel Approaches to Reduce and Reverse Bleeding in Complex PCI
8 min.
The Importance of Addressing Lipids in Patients With Complex PCI
8 min.
Periprocedural MI Matters to All Patients!
4 min.
Does It Matter What Stent I Use in a HBR Patient?
8 min.
New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents
8 min.
My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI
8 min.
New and Emerging Pharmacology for ACS: Factor XI Inhibition
6 min.
PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy
7 min.
P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?
7 min.
Short DAPT or De-Escalation After ACS
7 min.
Does Bleeding Risk Outweigh Thrombotic Risk or Vice Versa?
8 min.